Current Report Filing (8-k)
February 01 2023 - 6:08AM
Edgar (US Regulatory)
0001851182
false
--12-31
0001851182
2023-01-31
2023-01-31
0001851182
fhlt:UnitsEachConsistingOfOneShareOfCommonStockAndOnehalfOfOneRedeemableWarrantMember
2023-01-31
2023-01-31
0001851182
us-gaap:CommonStockMember
2023-01-31
2023-01-31
0001851182
fhlt:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50PerShareMember
2023-01-31
2023-01-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 31, 2023 (January 31, 2023)
Future Health ESG Corp.
(Exact name of registrant as specified in its
charter)
Delaware |
|
001-40788 |
|
86-2305680 |
(State
or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
8 The Green, Suite 12081
Dover, DE 19901
(Address of principal executive offices, including
zip code)
(Registrant’s telephone number,
including area code): (833) 388-8734
Not Applicable
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Units, each consisting of one share of common stock and one-half of one redeemable Warrant |
|
FHLTU |
|
The Nasdaq Stock Market LLC |
Common stock, par value $0.0001 per share |
|
FHLT |
|
The Nasdaq Stock Market LLC |
Redeemable warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share |
|
FHLTW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
|
Item 5.03. |
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On January 31, 2023, Future
Health ESG Corp., a Delaware corporation (the “Company”), held a special meeting of stockholders (the “Meeting”).
At the Meeting, the Company’s stockholders approved an amendment (the “Charter Amendment”) to the Company’s
Amended and Restated Certificate of Incorporation to decrease the number of authorized shares of common stock, par value $0.0001 per share,
from 500,000,000 to 26,000,000. On January 31, 2023, the Company filed a copy of the Charter Amendment with the Secretary of State of
the State of Delaware. A copy of the Charter Amendment is attached as Exhibit 3.1 hereto and is incorporated herein by reference.
|
Item 5.07. |
Submission of Matters to a Vote of Security Holders. |
At the Meeting, the Company’s
stockholders approved the Charter Amendment to decrease the number of authorized shares of common stock, par value $0.0001 per share,
from 500,000,000 to 26,000,000 (the “Charter Amendment Proposal”).
The final voting results
for the Charter Amendment Proposal were as follows:
For | | |
Against | | |
Abstain |
| 4,802,623 | | |
| 0 | | |
| 0 |
|
Item 9.01 |
Financial Statements and Exhibits. |
(d) |
Exhibits. The following exhibits are filed with this Form 8-K: |
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: January 31, 2023
|
FUTURE HEALTH ESG CORP. |
|
|
|
|
By: |
/s/ Bradley A. Bostic |
|
Name: |
Bradley A. Bostic |
|
Title: |
Chief Executive Officer |
Future Health ESG (NASDAQ:FHLT)
Historical Stock Chart
From Oct 2024 to Nov 2024
Future Health ESG (NASDAQ:FHLT)
Historical Stock Chart
From Nov 2023 to Nov 2024